Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Alexander

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
Cell Reports|May 10, 2023
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cellsAnabel Zelceski, Paola Francica, Lea Lingg, et al.
Substance Use & Addiction Journal|April 15, 2025
Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical ProtocolsMargaret Shang, Ilana Hull, Jane M Liebschutz, et al.
Revista Colombiana De Psiquiatria|November 15, 2025
Barriers to Access to Mental Health Services in Pregnant Women With Mental Pathology Residing in ColombiaSantiago Mora Martínez, Jorge Eliécer Gaitán Sánchez, Nathaly Berrío García, et al.
Oncogene|February 12, 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinomaJames Stewart, Dragomir B Krastev, Rachel Brough, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 9, 2025
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over timeKezang C Tshering, Marina T DiStefano, Andrea M Oza, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 23, 2025
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over timeKezang C Tshering, Marina T DiStefano, Andrea M Oza, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Frontiers in Neuroscience|September 8, 2016
TS-EUROTRAIN: A European-Wide Investigation and Training Network on the Etiology and Pathophysiology of Gilles de la Tourette SyndromeNatalie J Forde, Ahmad S Kanaan, Joanna Widomska, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 24, 2019
Evaluating the value of intrapartum fetal scalp blood sampling to predict adverse neonatal outcomes: A UK multicentre observational studyBassel H Al Wattar, Aarti Lakhiani, Adalina Sacco, et al.
The Bone & Joint Journal|May 1, 2024
Controversies in orthopaedic oncologyLee M Jeys, Joachim Thorkildsen, Vineet Kurisunkal, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
Cell Reports|May 10, 2023
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cellsAnabel Zelceski, Paola Francica, Lea Lingg, et al.
Substance Use & Addiction Journal|April 15, 2025
Building Multidisciplinary Consensus on Inpatient Xylazine Management through Clinical ProtocolsMargaret Shang, Ilana Hull, Jane M Liebschutz, et al.
Revista Colombiana De Psiquiatria|November 15, 2025
Barriers to Access to Mental Health Services in Pregnant Women With Mental Pathology Residing in ColombiaSantiago Mora Martínez, Jorge Eliécer Gaitán Sánchez, Nathaly Berrío García, et al.
Oncogene|February 12, 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinomaJames Stewart, Dragomir B Krastev, Rachel Brough, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 9, 2025
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over timeKezang C Tshering, Marina T DiStefano, Andrea M Oza, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 23, 2025
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over timeKezang C Tshering, Marina T DiStefano, Andrea M Oza, et al.
Immunity|May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell deathJonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Frontiers in Neuroscience|September 8, 2016
TS-EUROTRAIN: A European-Wide Investigation and Training Network on the Etiology and Pathophysiology of Gilles de la Tourette SyndromeNatalie J Forde, Ahmad S Kanaan, Joanna Widomska, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 24, 2019
Evaluating the value of intrapartum fetal scalp blood sampling to predict adverse neonatal outcomes: A UK multicentre observational studyBassel H Al Wattar, Aarti Lakhiani, Adalina Sacco, et al.
The Bone & Joint Journal|May 1, 2024
Controversies in orthopaedic oncologyLee M Jeys, Joachim Thorkildsen, Vineet Kurisunkal, et al.
Pageof 28